Micromet backs Joseph Lobacki as CCO
This article was originally published in Scrip
Jospeh Lobacki has joined biopharmaceutical company Micromet, which is developing antibody-based therapies for the treatment of cancer, as senior vice-president and chief commercial officer. Mr Lobacki has 25 years' commercial experience in the biopharmaceutical industry. From 2003 to 2011, he served as senior vice-president and general manager of transplant and oncology at Genzyme.